Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel D Stern

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Clinical Pharmacology and Therapeutics|April 2, 2024
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.govLars Masanneck, Ariel D Stern
Clinical Pharmacology and Therapeutics|April 9, 2025
Participants in the FDA's Biomarker Qualification ProgramMahnum Shahzad, Ariel D Stern
Clinical Pharmacology and Therapeutics|February 3, 2024
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device FirmsCaroline Marra, Ariel D Stern
Nature Biomedical Engineering|July 7, 2019
Challenges and opportunities in software-driven medical devicesWilliam J Gordon, Ariel D Stern
JAMA Cardiology|November 3, 2017
The Central and Unacknowledged Role of the US Food and Drug Administration in the Design and Execution of Medical Device Pivotal TrialsAaron V Kaplan, Ariel D Stern
Health Affairs (Project Hope)|September 8, 2021
Biosimilars And Follow-On Products: The Authors ReplyAriel D Stern, Mark R Trusheim
The American Journal of Bioethics : AJOB|June 22, 2026
Carrots and Sticks: Incentives in Shaping Digital Health ProductsCarmel Shachar, Eric Bressman, Ariel D Stern
Health Affairs (Project Hope)|September 6, 2022
Rapid Growth Of Remote Patient Monitoring Is Driven By A Small Number Of Primary Care ProvidersMitchell Tang, Ateev Mehrotra, Ariel D Stern
NPJ Digital Medicine|July 21, 2020
Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countriesSara Gerke, Ariel D Stern, Timo Minssen
Clinical Pharmacology and Therapeutics|October 17, 2017
Innovation Incentives and BiomarkersAriel D Stern, Brian M Alexander, Amitabh Chandra
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Clinical Pharmacology and Therapeutics|April 2, 2024
Tracing Digital Therapeutics Research Across Medical Specialties: Evidence from ClinicalTrials.govLars Masanneck, Ariel D Stern
Clinical Pharmacology and Therapeutics|April 9, 2025
Participants in the FDA's Biomarker Qualification ProgramMahnum Shahzad, Ariel D Stern
Clinical Pharmacology and Therapeutics|February 3, 2024
Tepid Uptake of Digital Health Technologies in Clinical Trials by Pharmaceutical and Medical Device FirmsCaroline Marra, Ariel D Stern
Nature Biomedical Engineering|July 7, 2019
Challenges and opportunities in software-driven medical devicesWilliam J Gordon, Ariel D Stern
JAMA Cardiology|November 3, 2017
The Central and Unacknowledged Role of the US Food and Drug Administration in the Design and Execution of Medical Device Pivotal TrialsAaron V Kaplan, Ariel D Stern
Health Affairs (Project Hope)|September 8, 2021
Biosimilars And Follow-On Products: The Authors ReplyAriel D Stern, Mark R Trusheim
The American Journal of Bioethics : AJOB|June 22, 2026
Carrots and Sticks: Incentives in Shaping Digital Health ProductsCarmel Shachar, Eric Bressman, Ariel D Stern
Health Affairs (Project Hope)|September 6, 2022
Rapid Growth Of Remote Patient Monitoring Is Driven By A Small Number Of Primary Care ProvidersMitchell Tang, Ateev Mehrotra, Ariel D Stern
NPJ Digital Medicine|July 21, 2020
Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countriesSara Gerke, Ariel D Stern, Timo Minssen
Clinical Pharmacology and Therapeutics|October 17, 2017
Innovation Incentives and BiomarkersAriel D Stern, Brian M Alexander, Amitabh Chandra
Pageof 4